ABSTRACT
Results: Fifty-six FNAs from LNs with metastatic PTC were reviewed. AHCs were identified in 38 (68%) cases, while only PTC with classic cytologic features was seen in 18 (32%) cases. AHCs did not show diagnostic nuclear features of PTC and presented as large cells with abundant cytoplasm either vacuolated or dense. Nuclei varied from vesicular with prominent nucleoli to dark and smudgy. Thirty-one cases showed mixed AHCs and classic PTC, but seven cases (13% of all metastatic PTCs in LNs) consisted only of AHCs.

Conclusions: AHCs are an often unrecognized metastatic morphologic pattern of cystic PTC, as it does not show diagnostic classic nuclear features of PTC. AHCs are the predominant cytologic finding in approximately 13% of metastatic PTCs to neck LNs.
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy and represents 80% of thyroid cancers. It is four times more common in females and predominates in middle-aged adults (20-50 years old). Metastases to the cervical lymph nodes occur in 5% to 10% of patients, and it can represent the first clinical manifestation of disease in 20% of patients with PTC. 1 Metastases are commonly evaluated by fine-needle aspiration (FNA) cytology, either to confirm metastatic disease or determine the primary site. The accurate recognition of metastases from PTC is important for several reasons, including upgrading the pathologic stage and recommending neck lymph node dissection in certain patients. 2 Upon completion of this activity you will be able to:
• understand the clinical significance of metastatic papillary thyroid carcinoma (PTC).
• identify the classic cytomorphologic features of PTC and metastasis.
• describe the cytology and significance of "atypical histiocytoid cells" in metastatic PTC.
The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit TM per article. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity qualifies as an American Board of Pathology Maintenance of Certification Part II Self-Assessment Module.
The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.
Exam is located at www.ascp.org/ajcpcme.
The cytomorphologic features of primary and metastatic PTC are well described. A definitive FNA diagnosis is usually rendered when classic nuclear features are identified, including oval nuclei with nuclear enlargement, powdery chromatin with marginal nucleoli, nuclear grooves, and intranuclear pseudoinclusions. 3 We have noticed, however, that occasionally, metastatic PTC did not possess classic nuclear features of PTC and that many predominantly cystic PTCs were dominated by cells with a histiocytoid appearance. While there is limited available literature on the significance of atypical histiocytoid cells (AHCs) in association with PTC in primary thyroid lesions, 4, 5 to our knowledge, their presence has not been previously reported in metastatic PTC.
Materials and Methods
Approval for this study was obtained from our institutional review board from Cleveland Clinic. We reviewed all FNA cytologies of neck lymph nodes that were associated with prior or subsequent PTC on thyroidectomy specimens and/or had surgical follow-up. The study period ranged from January 1, 2007, to December 31, 2013. Each FNA specimen included a ThinPrep slide (Hologic, Marlborough, MA) and several Papanicolaoustained smears.
Slides were examined to assess for the presence of AHCs and describe their cytomorphologic spectrum. Also, morphologic features of PTC were evaluated, including sheets, papillary groups, nuclear enlargement, powdery chromatin, oval nuclei, marginal nucleoli, nuclear grooves, and nuclear pseudoinclusions.
Paraffin-embedded cell blocks are used in thyroid cytology sparingly at our institution. For the purpose of this study, when available, immunohistochemistry for TTF-1 (predilute; Ventana Medical Systems, Tucson, AZ), CD68 (KP1, predilute; Ventana Medical Systems), cytokeratin AE1/AE3 (1:200; Millipore, St Louis, MO), thyroglobulin (1:8,000; Dako, Santa Clara, CA), PAX8 (1:200; ProteinTech Group, Rosemont, IL), and CD 163 (1:200; Biocare, Concord, CA) immunostains were performed to attempt to characterize the immunoprofile of the AHCs. Six cell blocks were available, but only three had adequate cellularity for immunohistochemistry.
Results
Fifty-six FNAs were reviewed from 52 patients, including 25 males and 27 females (age range, 17-88 years; mean age, 44 years). AHCs were identified in 38 (68%) of 56 cases, while the remaining 18 (32%) cases showed pure PTC with classic nuclear features (unassociated with AHCs) ❚Figure 1❚. Seven cases had only AHC (18% of AHC cases and around 13% of all lymph nodes involved by metastatic PTC). A cystic background was seen in 31 (82%) of 38 AHC cases, while 31 (82%) of 38 AHC cases had mixed AHC and PTC components ❚Image 1❚. The seven pure AHC cases (unaccompanied by classic PTC) had variable cellularity, with two cases showing fewer than five clusters of AHCs per slide. In five (9%) of 56 cases, FNA represented the initial diagnosis with no history of thyroid pathology, and two of these cases had only AHC.
AHCs had for the most part a histiocytic or epithelioid appearance, including large cells with abundant cytoplasm and high nuclear to cytoplasmic ratio. AHCs, however, did not show classic nuclear features of PTC. They presented mostly as single cells and occasional loose clusters. Two predominant cell types of AHCs were ❚Figure 1❚ Distribution of fine-needle aspirations (FNAs) from the study with subcategorization of cases that contained atypical histiocytoid cells (AHCs), pure papillary thyroid carcinoma (PTC), and mixed patterns.
❚Image 1❚ Atypical histiocytoid cells (upper left) admixed with sheets of papillary thyroid carcinoma with classic cytomorphologic features (lower right) (Papanicolaou stain, ×100).
recognized, based on their cytoplasmic appearance: (1) hypervacuolated cytoplasm and (2) dense cytoplasm. Most AHCs were of the hypervacuolated cytoplasm type. The hypervacuolated AHCs were large cells with abundant microvacuolated cytoplasm (multiple well-defined vacuoles) and had vesicular nuclei with prominent nucleoli ❚Image 2❚. A minor population of AHCs had dense cytoplasm with a polygonal or hobnail shape, very dense cytoplasm with well-defined borders, and eccentrically placed, very hyperchromatic or vesicular nuclei ❚Image 3❚. Not infrequently, those two types of cells were intermixed ❚Image 4❚. Few cases (11/38, 29%) showed intranuclear inclusions in the AHCs, but other diagnostic nuclear features of PTC were not seen in those cells.
Lymph node resection was performed on 53 of 56 cases, which confirmed the diagnosis of metastatic PTC ❚Image 5❚. One patient was followed by serum thyroglobulin levels, and another received radioactive iodine therapy.
Immunohistochemistry was performed on three cases. The AHCs showed positive staining with cytokeratin AE1/AE3 (cytoplasmic), thyroglobulin (cytoplasmic), TTF-1 (nuclear), and PAX-8 (nuclear). The same immunoprofile was identified in the groups of typical PTC cells. Background macrophages related to cyst contents stained positive with CD68 and CD163 immunostains and negative with other markers. 
Discussion
The classic FNA presentation of metastatic PTC in lymph nodes includes sheets and clusters of cells with diagnostic PTC nuclear features, such as nuclear enlargement, powdery chromatin, nuclear grooves, and pseudoinclusions. In the absence of these diagnostic PTC nuclear features, establishing or suspecting metastatic PTC on FNA can be a diagnostic challenge. This can be especially problematic in patients with no history of PTC. Our current study found that predominantly cystic metastatic PTC to lymph nodes may be dominated by atypical histiocytoid-appearing malignant cells that lack classic nuclear features of PTC (approximately 13% of ❚Image 4❚ Atypical histiocytoid cells with intermixed dense and hypervacuolated cytoplasm (A, Papanicolaou stain, ×400; B, cell block, H&E, ×400).
❚Image 5❚ A, Metastatic cystic papillary thyroid carcinoma to the neck (H&E, ×40). B, High-power view reveals cyst-lining cells with cytologic features identical to atypical histiocytoid cells seen on fine-needle aspiration (H&E, ×400).
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AHCs have not been well described in the literature, with only two reports, totaling nine cases with adequate follow-up, addressing their significance in thyroid FNAs. 4, 5 Six (66%) of those nine cases had only AHCs, which showed PTC on surgical follow-up. Three remaining cases demonstrated diagnostic PTC nuclear features in other passes from the same nodules. Renshaw 4 also examined FNA of 50 benign cystic lesions for comparison, and none were found to have AHCs. The Bethesda System for reporting thyroid cytopathology has one sentence in reference to AHCs and includes it under the category "Suspicious for PTC, cystic degeneration pattern." 3 Two more recent publications reported cytology of metastatic PTC to the neck but mainly focused on cystic lesions with macrophages as a possible cause of false-negative results. 7, 8 There was no mention of AHCs as a contributing component. Tseng et al 7 compared cytologic characteristics of 47 metastatic PTCs in cervical lymph nodes with 38 primary thyroid PTCs and found that there were no significant morphologic differences between primary and metastatic PTCs. Koo et al 8 proposed the use of FNA thyroglobulin measurements to increase the sensitivity of metastatic PTC in neck lymph nodes and avoid false-negative diagnoses in predominately cystic metastatic PTC.
Although AHCs have been reported in FNA of primary PTC, to our knowledge, they have not been reported in metastatic PTC. Our study demonstrated that AHCs were identified in FNAs from 38 (68%) of 56 metastatic PTCs to neck lymph nodes and were associated with predominately cystic change in 31 (82%) of 38 cases. Although most AHC cases were accompanied by cells with diagnostic nuclear features of PTC (82%), seven cases were composed only of AHC and lacked nuclear features of PTC. Those seven cases represented 18% of AHC cases and 13% of all metastatic PTCs involving lymph nodes in our study.
AHCs present mostly as single cells and loose clusters. They are large cells with abundant cytoplasm and a histiocytic or epithelioid appearance. We found them to exist mostly as two cell types, based on the morphologic appearance of the cytoplasm. The first cell type is characterized by hypervacuolated cytoplasm with vesicular nuclei and prominent nucleoli. The second cell type has very dense cytoplasm with eccentrically placed (hobnail-like) dark atypical and smudgy nuclei or vesicular nuclei with prominent nucleoli. Those two AHC cell types may exist separately or in combination. Most AHCs had hypervacuolated cytoplasm, but occasional cells with dense cytoplasm showed some vacuoles, and not infrequently, both cell types coexisted in the same cluster of cells.
Since AHCs appear to be commonly associated with cystic changes as a result of contact with the cyst fluid, they may represent neoplastic cells that have undergone degenerative changes in the form of vacuolization and repair-like appearance. The epithelial nature and thyroid origin of these cells were confirmed by their immunohistochemical profile.
Differential diagnosis of AHCs includes benign histiocytes, reparative changes associated with cystic change, hobnail variant of PTC, metastatic renal cell carcinoma, and high-grade carcinoma not otherwise specified. Due to its abundant vacuolated cytoplasm, AHCs may be confused with macrophages, leading to a false-negative diagnosis of benign cyst contents. Benign histiocytes have a low nuclear to cytoplasmic ratio, foamy vacuolated cytoplasm, and small nuclei with no significant atypia. AHCs, on the other hand, have large atypical nuclei that may be smudgy or vesicular in nature, and the cytoplasm tends to contain larger sized vacuoles with well-defined borders. Immunohistochemistry may be helpful in certain cases, as macrophages will stain positive with histiocytic markers such as CD68, 6 whereas AHCs are epithelial in nature and stain positive with AE1/3 and TTF-1. 4, 5 The AHCs in our study showed positive staining with cytokeratin AE1/AE3 (cytoplasmic), thyroglobulin (cytoplasmic), TTF-1 (nuclear), and PAX-8 (nuclear). These findings, along with negative staining for histiocytic markers (CD68 and CD163), support the epithelial thyroid follicular origin of the AHCs. Immunohistochemistry can help confirm the thyroid follicular origin of the AHCs if a cell block is available. AHCs may be confused with repair, as they may present in flat sheets with dense cytoplasm. Repair, though, shows uniform-appearing nuclei with fine, evenly distributed chromatin and no significant pleomorphism. AHCs, in contrast, show a high nuclear to cytoplasmic ratio, dark smudgy nuclei, and significant nuclear pleomorphism.
The hobnail variant of PTC has been described to be associated with an aggressive behavior, with a high incidence of infiltrative tumors and metastatic disease. 9 AHCs may have some cells with hobnail-like appearance, but these are usually isolated in nature and focally present. FNA aspirates of the hobnail variant of PTC, on the other hand, are usually highly cellular, are clustered, and have a distinct micropapillary configuration.
AHCs may raise the possibility of metastatic renal cell carcinoma due to the vacuolated nature of their cytoplasm. Renal cell carcinoma, in contrast to AHCs, presents mostly in sheets with occasional single cells, frayed © American Society for Clinical Pathology AJCP / Original article cytoplasmic borders (AHCs have well-defined cytoplasmic borders), and often associated with vascularized epithelial fragments. 10, 11 Immunohistochemistry may be used in this differential diagnosis if needed, as renal cell carcinoma stains positive with renal cell antigen and negative with TTF-1 and thyroglobulin.
12 PAX-8 is not helpful in this differential diagnosis, since both PTC and renal cell carcinoma will show positive staining.
Finally, the absence of recognizable and diagnostic PTC nuclear features in AHCs may lead to a mistaken diagnosis of poorly differentiated carcinoma of unknown primary origin, especially in the absence of a history of malignancy. Recognition of this cytologic pattern as one of the faces of metastatic PTC, however, can initiate evaluation of thyroid as a possible primary site in patients with no history or confirm metastatic PTC in patients with a history of PTC. Recognition of this cytologic pattern can also initiate an appropriate panel of immunocytochemical stains for confirmation of thyroid origin, including TTF-1, thyroglobulin, and PAX-8.
In summary, AHCs represent an underrecognized metastatic pattern of PTC, which is most commonly associated with cystic lesions. This is encountered in approximately 13% of metastatic PTCs to neck lymph nodes. Familiarity with the cytomorphology of AHCs in the absence of classic PTC nuclear features may provide the only clue to avoiding a false-negative diagnosis or suspecting a primary thyroid origin of metastatic disease.
